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ABSTRACT
Background: Bloodstream infections are often
associated with significant mortality and morbidity.
We aimed to investigate changes in the epidemiology
of bloodstream infections in Switzerland between 2008
and 2014.
Methods: Data on bloodstream infections were
obtained from the Swiss antibiotic resistance
surveillance system (ANRESIS).
Results: The incidence of bloodstream infections
increased throughout the study period, especially
among elderly patients and those receiving care in
emergency departments and university hospitals.
Escherichia coli was the predominant pathogen, with
Enterococci exhibiting the most prominent increase
over the study period.
Conclusions: The described trends may impact
morbidity, mortality and healthcare costs associated
with bloodstream infections.
INTRODUCTION
Bloodstream infections (BSIs) are associated
with signiﬁcant morbidity and mortality. The
inﬂuence of multiple factors, such as the
increases in longevity and comorbidities and
the use of more invasive technologies,1 could
lead to secular changes in the epidemiology
of BSIs.
Only few nationwide studies have focused
on the incidence of BSIs, and their results
were often inconsistent. A study from
England described an increasing incidence
of BSIs until 2006, followed by decline
between 2006 and 2008.1 A signiﬁcant
decrease in BSIs was also observed in a
Danish population-based study which
included data until 2008.2 On the other
hand, a report from Finland showed an
increase in episodes of BSI until 2007,3 and a
European surveillance study from the
EARS-Net suggested an increase of the
burden of BSI until 2008 based on trends of
the ﬁve major bacterial pathogens.4 To the
best of our knowledge, recent analyses of
population-based studies have not been pub-
lished. The present work aims to describe
temporal trends in BSI incidence between
2008 and 2014 in Switzerland, using the
national surveillance system.
METHODS
Data on BSIs were obtained from the Swiss
centre for antibiotic resistance surveillance
(ANRESIS). Since 2004, the ANRESIS pro-
gramme has collected all routine microbio-
logical data from a representative group of
microbiology laboratories located across
Switzerland, with blood culture surveillance
introduced in 2006. Each participating
laboratory sends bacteraemia results on a
regular basis to a central database located at
the Institute for Infectious Diseases in Bern,
Switzerland. We restricted the data set to
acute care hospitals that continuously re-
ported ≥5 BSIs per year without major ﬂuc-
tuations from 2008 through 2014.
Unfortunately, not all hospitals send negative
blood culture results to the central database.
The analysed data set represents approxi-
mately one-third (26 hospitals) of all acute
care hospitals in Switzerland5 with institutions
being evenly distributed across the country.
Positive blood cultures were grouped as
episodes of BSI if they occurred in a 7-day
time window for a given patient.
Coagulase-negative Staphylococci (CoNS) and
Strengths and limitations of this study
▪ We performed a retrospective analysis of blood-
stream infections in Switzerland.
▪ We analysed data from ANRESIS, a large national
bloodstream infection database (Swiss centre for
antibiotic resistance surveillance).
▪ Twenty-six acute Swiss hospitals were included.
▪ No data on mortality was included.
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other typical skin commensals (see online
supplementary appendix) were considered as an infec-
tion if identiﬁed in >1 blood culture, or in one blood
culture and a catheter tip within the same episode;
otherwise they were considered as contaminants and
excluded from the analysis. A BSI was considered
polymicrobial if different microbial species were identi-
ﬁed during the same episode. For a more detailed trend
analysis, the following microorganisms groups were
selected: Escherichia coli, Staphylococcus aureus, non-E. coli
Enterobacteriaceae, polymicrobial BSI, CoNS and
Enterococcus spp. A subanalysis of the following categories
was performed: department (outpatient, emergency or
other department vs other), age (<65 vs ≥65 years),
gender (male vs female) and type of hospital (commu-
nity hospital vs university hospital).
Incidence rates were based on the number of reported
bacteraemia isolates per 100 000 population. Since our
data are from ∼33% of the acute care hospital beds in
Switzerland, we attempted to forecast the incidence in
the total population by simple linear extrapolation,
based on population statistics.5 6 This assumes both that
the community is uniformly served by the available beds,
and that the 33% is a representative sample of the sec-
ondary and tertiary care infrastructures.5 We investigated
the latter in the context of a simple sensitivity analysis,
whereby the split of 50%:50% primary to tertiary care
beds present in our sample data was altered to reﬂect
that in the whole country (80%:20%). Despite being
rather crude in nature, the simple change in propor-
tions provides the most straightforward method for
investigating plausible differences in the population as a
whole.
Unadjusted models for the mean increase in bacter-
aemia per year were ﬁtted using generalised linear
models with Poisson distribution and loglink function,
using an offset for the sample population estimate in
the appropriate year.
Adjusted models were investigated by including
gender, age (above or below 65 years), microorganism
group (6 groups), hospital type (community or univer-
sity), hospital department (outpatient, emergency or
otherwise) and number of contaminants as covariates.
Poisson goodness of ﬁt was tested using the χ2 test.
Overdispersion was investigated using the likelihood
ratio test with subsequent ﬁtting of a negative binomial
model, if appropriate.
A signiﬁcance level of 5% was used with p values
determined using Wald-type statistics and 95% CIs. All
statistical analyses were performed in R.
RESULTS
A total of 40 378 BSIs were reported between 2008 and
2014, with a mean incidence rate of 220 episodes per
100 000 population. The incidence rate increased by
14%, from 211 in 2008 to 240 per 100 000 population in
2014 (p<0.001, ﬁgure 1), while contaminant episodes
(not included in the following analysis) remained con-
stant over this period. The sensitivity analysis described
above revealed lower incidence rates of BSI (from 174
in 2008 to 197 per 100 000 population in 2014), but the
same 14% increase for this period (p<0.001).
In adjusted models, among the patients with BSI, we
observed an increase in number of BSIs in individuals
≥65 years (from 119 to 144 episodes per 100 000 popu-
lation, mean increase of 3.0% per year, p<0.001). A sup-
plementary analysis eliminating the bias of population
growth in the speciﬁc at-risk population also revealed an
increase in the incidence (from 705 in 2008 to 796 per
100 000, p<0.001) in older people (≥65 years). An addi-
tional analysis for lower ages did not indicate any signiﬁ-
cant trends (refer to the online supplementary
appendix table A). We observed a signiﬁcant increase of
BSI diagnosed in emergency departments (from 58 to
79 per 100 000 population, +5.2% per year, p<0.001)
and in university hospitals (from 105 to 125 per 100 000
population, +2.8% per year, p<0.001).
In 2014, E. coli was the most frequently detected micro-
organism (73 per 100 000 population, 30.5% of all epi-
sodes). Seventy per cent of all BSIs were caused by
E. coli, S. aureus, polymicrobial BSI, CoNS, non-E. coli
Enterobacteriaceae or Enterococci. All microorganism groups
exhibited an increasing trend (ﬁgure 2), although this
was only marginal for S. aureus (from 28 to 29 per
100 000, p=0.05). Enterococci displayed a steeper relative
trend than other pathogens (from 9 to 14 per 100 000
population, +8.4% per year, p<0.001).
DISCUSSION
To the best of our knowledge, no national studies on
recent BSI trends have been published in the past few
years.1 2 4 In this nationwide BSI surveillance study, we
observed a 14% increase in BSI incidence in Switzerland
between 2008 and 2014. Published European data from
before 2008 show variable trends, with increasing
Figure 1 Incidence in bloodstream infections 2008–2014:
trends overall and for subgroups. Note: *significant increase
(p<0.001). BSI, bloodstream infection; dept, department.
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bacteraemia rates in Finland from 2004 to 20073 and
England from 2004 to 20061 but decreasing rates in
England from 2006 to 20081 and Denmark from 2000 to
2008.2 Overall, the increase in BSI was more prominent
in emergency departments. This could be due to a
decreasing average duration of hospitalisation7 with dis-
charge of sicker patients who are prone to readmission,
for example, in case of surgical wound infection. This
phenomenon appeared to be more pronounced in
elderly people, even after adjusting for changes in the
longevity of the underlying population. An alternative
explanation could be the increasing number of immi-
grants6 who tend to seek medical help not in private
practices, but in emergency departments, where blood
cultures are drawn more liberally. Moreover, as previ-
ously observed,8 we cannot rule out an upward trend in
healthcare-associated infections overall or subtle
changes in blood culture ordering practice leading to
improved diagnosis of BSI.
The absolute BSI incidence rate observed in our study
was higher than that reported in the majority of
population-based studies1 3 9 with the exception of a
report from Denmark.2 As shown in the sensitivity ana-
lysis, our main analysis overestimated the incidence rate
due to an over-representation of university hospitals in
the data set. It has been described before that BSI inci-
dence rates are higher in university compared with com-
munity hospitals,10 and indeed, following correction for
hospital type, incidence rates were comparable to the
aforementioned population-based studies.
As expected,9 E. coli presents as the most important
cause of bacteraemia in Switzerland. Our data also
revealed increasing incidences of E. coli and non-E. coli
Enterobacteriaceae over time, as observed in England
between 2004 and 2008.1 This trend could be explained
by several factors. BSIs were increasingly detected in
emergency departments, a marker for infections
acquired in the community, and in older people, who
are known to be at higher risk for E. coli BSI.11 12
Moreover, while the incidence of S. aureus bacteraemia
remained stable over time, the marked upward trend in
BSIs caused by Enterococci is of particular concern, since
they may be associated with higher mortality.13 We were
unable to identify a predisposing factor for the increase
in enterococcal BSIs. However, an association with inten-
sive care unit departments and vulnerable patients with
frequent exposure to the healthcare system is
conceivable.13 14
Our study has several limitations. First, we extrapolated
incidence based on the epidemiology of only 33% of all
Swiss acute hospitals and, consequently, the generalis-
ability of our ﬁndings may be somewhat limited. A
simple sensitivity analysis reﬂecting the actual percent-
age split between university and community hospitals
did not reveal any signiﬁcant differences. Even consider-
ing this, the study does not include BSIs diagnosed in
long-term care facilities and by general practice physi-
cians. The second potential limitation is that we consid-
ered an episode as being polymicrobial if multiple
microorganisms were isolated within 1 week, which
could inﬂuence the BSI incidence estimates. The lack of
a widely accepted deﬁnition for what constitutes polymi-
crobial BSI complicates the evaluation of its incidence.
Finally, no reliable information regarding the total
number of drawn blood cultures is available in the
ANRESIS database. Unfortunately, not all hospitals send
negative blood culture results to the central laboratories
and we are therefore unable to present the total
number of blood cultures taken.
In conclusion, in this extrapolated Swiss population-
based study we describe an increase in BSIs between
2008 and 2014, especially in those detected in emer-
gency room patients. The role of E. coli continues to
become more prominent, while Enterococci showed the
greatest increase over the study period. The described
trends may impact morbidity, mortality and healthcare
costs associated with BSI.
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